BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6212162)

  • 21. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental coxsackie B virus myocarditis in mice: 18 month histopathological and virological study.
    Kutaura Y
    Jpn Circ J; 1981 Jul; 45(7):747-62. PubMed ID: 6267334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.
    Tominaga M; Matsumori A; Okada I; Yamada T; Kawai C
    Circulation; 1991 Jun; 83(6):2021-8. PubMed ID: 1674900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy.
    Kyu B; Matsumori A; Sato Y; Okada I; Chapman NM; Tracy S
    Circulation; 1992 Aug; 86(2):522-30. PubMed ID: 1322254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic findings in experimental murine myocarditis--arrhythmias in the chronic stage.
    Kishimoto C; Matsumori A; Kawai C
    Jpn Circ J; 1983 Nov; 47(11):1317-21. PubMed ID: 6315986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical findings in acute viral myocarditis. With special attention to experimental and immunological evidence.
    Kishimoto C; Tomioka N; Kawai C
    Herz; 1985 Feb; 10(1):15-20. PubMed ID: 2984098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathologic features of arrhythmogenic right ventricular cardiomyopathy with severe heart failure].
    Wang HY; Liu L; Li L; Wang LL; Lü FY; Zhao H; Song LF; Pu JL
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):169-73. PubMed ID: 18788593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbred mice infected by an encephalomyocarditis virus variant: a model for studying chronic viral heart disease.
    Kruppenbacher JP; Arnold G; Mertens T; Fischer A; Zimmermann J; Eggers HJ
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):405-13. PubMed ID: 8391736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model.
    Matsumori A; Crumpacker CS; Abelmann WH
    J Am Coll Cardiol; 1987 Jun; 9(6):1320-5. PubMed ID: 3034992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice.
    Shioi T; Matsumori A; Sasayama S
    Circulation; 1996 Dec; 94(11):2930-7. PubMed ID: 8941123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparation.
    Kishimoto C; Spry CJ; Tai PC; Tomioka N; Kawai C
    Jpn Circ J; 1986 Dec; 50(12):1264-7. PubMed ID: 3029448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous myocarditis in DBA/2 mice. Light microscopic study with transmission and X-ray analytical electron microscopic studies.
    Hirasawa M; Kitaura Y; Deguchi H; Ukimura A; Kawamura K
    Virchows Arch; 1998 May; 432(5):461-8. PubMed ID: 9645447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis in congestive heart failure induced by viral myocarditis in mice.
    Yamada T; Matsumori A; Wang WZ; Ohashi N; Shiota K; Sasayama S
    Heart Vessels; 1999; 14(1):29-37. PubMed ID: 10543311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial uptake of antimyosin monoclonal antibody in a murine model of viral myocarditis.
    Matsumori A; Ohkusa T; Matoba Y; Okada I; Yamada T; Kawai C; Tamaki N; Watanabe Y; Yonekura Y; Endo K
    Circulation; 1989 Feb; 79(2):400-5. PubMed ID: 2536600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral administration of L-arginine prevents congestive heart failure in murine viral myocarditis.
    Hiraoka Y; Kishimoto C; Takada H; Ochiai H
    J Cardiovasc Pharmacol; 2002 Jul; 40(1):1-8. PubMed ID: 12072571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
    Tanaka A; Matsumori A; Wang W; Sasayama S
    Circulation; 1994 Oct; 90(4):2051-5. PubMed ID: 7923693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle.
    Matsumori A; Kawai C
    J Pathol; 1980 Jun; 131(2):97-106. PubMed ID: 6253611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of myocardial damage and alteration of lymphocyte subsets in murine model of postpartum myocarditis.
    Yokoyama T; Kanda T; Suzuki T; Murata K
    Am J Cardiovasc Pathol; 1993; 4(4):343-51. PubMed ID: 8305197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.
    Yamada T; Matsumori A; Okada I; Tominaga M; Kawai C
    Jpn Circ J; 1992 Nov; 56(11):1138-45. PubMed ID: 1360548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
    Yamada T; Matsumori A; Sasayama S
    Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.